Dr. Erica Bo Kyung Wang, MD

Dr. Wang practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Wang's NPI, 1780039644, was assigned on April 28, 2016. Dr. Wang graduated from John A. Burns School of Medicine in 2016. Dr. Wang holds California license A156279.

Dr. Wang's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Wang's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Wang to 1 more hospital and 1 medical group, each named with a free account. Dr. Wang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wang is board certified in dermatology by the American Board of Dermatology. Dr. Wang is licensed in California.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Wang treats.

CMS data shows 750 Medicare services from Dr. Wang across 13 procedure codes in 2024, for 216 Medicare patients. Medicare paid $54,479 for them.

CMS counts 216 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 97 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 52, with 58% women.

In 2024, Dr. Wang wrote 467 Medicare Part D claims for 102 patients. 92% of them were for generic drugs. CMS names the drug for 332 of them, across 15 drugs with 11 or more claims each, at $104,306 in total drug cost. In 2023, CMS named 241 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth. CMS counts 154 procedures of skin biopsy by Dr. Wang, more than 81% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Wang, published from 2019 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Skin, Skin Neoplasms and Mycosis Fungoides. Dr. Wang has published most often in J Drugs Dermatol. Dr. Wang's most frequent co-authors are Jared Jagdeo, MD, Michael Siavash Khodadoust, MD, PhD and Sebastian Fernandez-Pol, MD.

CMS Open Payments shows 6 general payments to Dr. Wang from 3 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $202.

Dr. Wang graduated from John A. Burns School of Medicine in 2016.

Dr. Wang is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.